2.83 USD
-0.02 (-0.7%)
Taking everything into account, OKUR scores 2 out of 10 in our fundamental rating. OKUR was compared to 525 industry peers in the Biotechnology industry. OKUR has a great financial health rating, but its profitability evaluates not so good. OKUR has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
- OKUR had negative earnings in the past year.
- In the past year OKUR has reported a negative cash flow from operations.
- OKUR had negative earnings in each of the past 5 years.
- In the past 5 years OKUR always reported negative operating cash flow.
1.2 Ratios
- OKUR has a Return On Assets of -111.50%. This is in the lower half of the industry: OKUR underperforms 77.90% of its industry peers.
- OKUR's Return On Equity of -122.25% is on the low side compared to the rest of the industry. OKUR is outperformed by 60.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -111.5% | ||
| ROE | -122.25% | ||
| ROIC | N/A |
ROA(3y)-55.3%
ROA(5y)-45.4%
ROE(3y)-63.34%
ROE(5y)-51.1%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- OKUR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- Compared to 1 year ago, OKUR has more shares outstanding
- The number of shares outstanding for OKUR has been reduced compared to 5 years ago.
- There is no outstanding debt for OKUR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- OKUR has an Altman-Z score of -2.94. This is a bad value and indicates that OKUR is not financially healthy and even has some risk of bankruptcy.
- OKUR's Altman-Z score of -2.94 is in line compared to the rest of the industry. OKUR outperforms 46.86% of its industry peers.
- OKUR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -2.94 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- A Current Ratio of 11.45 indicates that OKUR has no problem at all paying its short term obligations.
- With an excellent Current ratio value of 11.45, OKUR belongs to the best of the industry, outperforming 85.90% of the companies in the same industry.
- A Quick Ratio of 11.45 indicates that OKUR has no problem at all paying its short term obligations.
- OKUR has a Quick ratio of 11.45. This is amongst the best in the industry. OKUR outperforms 85.90% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 11.45 | ||
| Quick Ratio | 11.45 |
3. Growth
3.1 Past
- OKUR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 61.06%, which is quite impressive.
EPS 1Y (TTM)61.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.91%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- OKUR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.26% yearly.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y29.21%
EPS Next 2Y19.23%
EPS Next 3Y14.82%
EPS Next 5Y13.26%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- OKUR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year OKUR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- OKUR's earnings are expected to grow with 14.81% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.23%
EPS Next 3Y14.82%
5. Dividend
5.1 Amount
- No dividends for OKUR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ONKURE THERAPEUTICS INC-A / OKUR FAQ
Can you provide the ChartMill fundamental rating for ONKURE THERAPEUTICS INC-A?
ChartMill assigns a fundamental rating of 2 / 10 to OKUR.
What is the valuation status for OKUR stock?
ChartMill assigns a valuation rating of 0 / 10 to ONKURE THERAPEUTICS INC-A (OKUR). This can be considered as Overvalued.
Can you provide the profitability details for ONKURE THERAPEUTICS INC-A?
ONKURE THERAPEUTICS INC-A (OKUR) has a profitability rating of 0 / 10.
What is the financial health of ONKURE THERAPEUTICS INC-A (OKUR) stock?
The financial health rating of ONKURE THERAPEUTICS INC-A (OKUR) is 7 / 10.